Phase 3 Search

Looking back on the past year, we're reflecting on what 2024 taught us—a challenging but rewarding year for Phase 3 Search and the biotech industry. Here are 3 key lessons we learned in 2024: 1️⃣ Resilience is key. The biotech industry faced its share of hurdles this year, but adaptability and determination pushed us forward. 2️⃣ People make the difference. From connecting with incredible candidates to partnering with visionary clients, we're reminded every day of the power of talent to drive change. 3️⃣ Celebrate the wins. Despite the challenges, we achieved major milestones, including completing our first CEO placement—a proud moment for the entire Phase 3 team. Here’s to carrying these lessons into 2025 and continuing to grow, connect, and make an impact. What did 2024 teach you? #BiotechLeadership #LessonsLearned #Resilience #Phase3Search #NewYearReflections

Your resume is more than just a list of experiences—it’s your gateway to leadership opportunities. Swipe through for some must-know tips to make your resume impactful, concise, and tailored for success for this upcoming year. Looking for additional guidance in your career search? Our Leaders in Transition Playbook provides a series of complimentary guides to help you refine your resume, tap into your network and advance to the next level in your career. Download it here: https://lnkd.in/d6cC2gzP #LeadershipTransition #ExecutiveResume #CareerGrowth #Phase3Search

It was a huge privilege to be part of the Executive Platforms' Biomanufacturing World Summit opening panel. Joined by Kawa Chiu, Rainer Müller, David Y. H. Chang, and chaired by Alison Moore we tackled The Five Biggest Things Facing Our Shared Biomanufacturing Future.    Watch our session here 🎥: https://lnkd.in/gK_p_Vna   #BMWS24 #Biomanufacturing #Biotech #Pharma #ExecutivePlatforms #Future #Phase3 #FierceAlternatives

As we prepare for 2025, the biotechnology industry stands at a pivotal moment. While 2024 brought significant challenges, including economic uncertainty and a surge in layoffs, the future holds incredible potential for transformation. Advancements in personalized medicine, artificial intelligence, and gene editing are reshaping the industry, requiring innovative strategies and diverse talent to drive progress. Despite the hurdles, the resilience and adaptability of the biotech community inspire confidence that growth and innovation are on the horizon. Together, we can navigate these changes and unlock the full potential of what’s to come. #BiotechLeadership #Innovation #Resilience #FutureOfBiotech #TalentAcquisition

"Breaking down silos can be the difference between hitting half your goals—or 80% of them." - Bob Ferrigno On our latest episode of The Phase 3 Biotech Leadership Podcast, Bob Ferrigno shares how a business process redesign transformed his team's success rate, moving from hitting only 50% of milestones to 80%. By uniting voices from across the organization, creating a common language, and aligning on shared goals, they accelerated product development, cut costs, and achieved a significant impact on the bottom line. His insight highlights a universal challenge, whether you’re in a Fortune 100 company or a small startup: silos can hold back progress. His career is a testament to the power of breaking down these barriers and ensuring every voice has a seat at the table. 🎧 Listen to the full episode for more insights on effective team collaboration: https://lnkd.in/g3ZS4PrQ #Leadership #TeamCollaboration #Silos #Biotech #Phase3Search #Podcast

Our CEO & Founder, Alex Cooke recently spoke at the #BMWS24, sharing insights on collaboration, innovation, and the future of biotech. From improving cell therapy production to championing enzymatic synthesis for RNA, the conference showcased some groundbreaking advancements shaping our industry. It’s clear that teamwork, streamlined processes, and a focus on patient outcomes are driving the biotech sector forward. A big thank you to Executive Platforms for the invitation and for organizing such an impactful event. If you're not signed up for #BMWS25, now’s the time! https://lnkd.in/e-DyS_QA #BiotechLeadership #Innovation #Collaboration #Phase3Search

"Strategy isn't just about planning—it’s about adapting, tracking, and following through." - Bob Ferrigno In our latest episode of The Phase 3 Biotech Leadership Podcast, Bob Ferrigno opens up about his journey in mastering strategic thinking. While he once felt like a novice in strategy, he learned that the key to success lies in simplifying the process: understanding the voice of the customer, identifying strengths and weaknesses, and building a clear, actionable plan. However, as Bob emphasizes, a strategy is only as strong as its execution. Monitoring progress, being honest about missed targets, and adapting when necessary are essential to driving real results. This is a must-listen for anyone looking to refine their strategic approach and stay focused on achieving objectives. 🎧 Listen to the full episode here: https://lnkd.in/g3ZS4PrQ #Leadership #Strategy #Biotech #Phase3Search #Podcast #Execution

Happy Thanksgiving from all of us at Phase 3 Search! We’re grateful for our clients, partners, and team members who make our work so rewarding. Wishing everyone a wonderful day filled with gratitude, joy, and time with loved ones.

🦤 Good morning data detectives, this week’s biotech stories reveal the unexpected…👇 📉 Hidden data on obesity prospect wipe $12B off Amgen market cap (Nick Paul Taylor) 👩🏻💻 Google DeepMind open-sources AlphaFold 3: A game-changer for drug discovery and biotech (Bernice Lottering) 🧠 Maze's ALS spinout Trace Neuroscience raises $101M for ALS and neuro work (Kyle LaHucik) 🧬 New AI model improves prediction power for genomics related to disease (Los Alamos National Laboratory) ❤️🩹 No more invasive tests: Hera Biotech’s endometriosis solution(Geri Stengel) Tune into… 🎧 She Leads Biotech with Ayla Annac and Sharron Cox 🎧 Building Effective Teams and Career Success with Bob Ferrigno and Alex Cooke 🎧 The Future of Healthcare: Insights from HLTH with Noe Gutierrez and Christopher Leidli Apply to… 📎 Senior Assay Development Scientist, Serna Bio 📎 Scientist In vivo Immuno-Oncology, Asgard Therapeutics 📎 Scientist, IONTAS RSVP… 📆 27.11 | SomX & Google Cloud Healthtech Talks Christmas Party 📆 03.12 | SynbiTECH 📆 09.12 | BioTech Networking Event Stay up to date with all the latest biotech news. Issue #23 out now: https://lnkd.in/gsd95HNa #biotechdodo #biotech #pharma #digitalhealth #healthtech

What sets Phase 3 apart in biotech executive search? Reason #7 - Pre-Search Stakeholder Discovery and Alignment At Phase 3 Search, we start every search by conducting in-depth interviews with your key internal stakeholders. This upfront work helps us align on interdepartmental needs and understand the capabilities and experience needed for the role. By generating a detailed profile and securing buy-in from the start, we ensure that the incoming leader is set up for success and can start delivering results faster. Looking for a search process that truly understands your organization’s needs? Contact us to see how we can help. https://ph3.bio/contact-us #ExecutiveSearch #Leadership #Biotech #StakeholderAlignment #Phase3Search